Find information on thousands of medical conditions and prescription drugs.

Pulmonary alveolar proteinosis

Pulmonary alveolar proteinosis (PAP) is a rare lung disease in which abnormal accumulation of surfactant occurs within the alveoli, interfering with gas exchange. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Arthritis
Arthritis
Bubonic plague
Hypokalemia
Pachydermoperiostosis
Pachygyria
Pacman syndrome
Paget's disease of bone
Paget's disease of the...
Palmoplantar Keratoderma
Pancreas divisum
Pancreatic cancer
Panhypopituitarism
Panic disorder
Panniculitis
Panophobia
Panthophobia
Papilledema
Paraganglioma
Paramyotonia congenita
Paraphilia
Paraplegia
Parapsoriasis
Parasitophobia
Parkinson's disease
Parkinson's disease
Parkinsonism
Paroxysmal nocturnal...
Patau syndrome
Patent ductus arteriosus
Pathophobia
Patterson...
Pediculosis
Pelizaeus-Merzbacher disease
Pelvic inflammatory disease
Pelvic lipomatosis
Pemphigus
Pemphigus
Pemphigus
Pendred syndrome
Periarteritis nodosa
Perinatal infections
Periodontal disease
Peripartum cardiomyopathy
Peripheral neuropathy
Peritonitis
Periventricular leukomalacia
Pernicious anemia
Perniosis
Persistent sexual arousal...
Pertussis
Pes planus
Peutz-Jeghers syndrome
Peyronie disease
Pfeiffer syndrome
Pharmacophobia
Phenylketonuria
Pheochromocytoma
Photosensitive epilepsy
Pica (disorder)
Pickardt syndrome
Pili multigemini
Pilonidal cyst
Pinta
PIRA
Pityriasis lichenoides...
Pityriasis lichenoides et...
Pityriasis rubra pilaris
Placental abruption
Pleural effusion
Pleurisy
Pleuritis
Plummer-Vinson syndrome
Pneumoconiosis
Pneumocystis jiroveci...
Pneumocystosis
Pneumonia, eosinophilic
Pneumothorax
POEMS syndrome
Poland syndrome
Poliomyelitis
Polyarteritis nodosa
Polyarthritis
Polychondritis
Polycystic kidney disease
Polycystic ovarian syndrome
Polycythemia vera
Polydactyly
Polymyalgia rheumatica
Polymyositis
Polyostotic fibrous...
Pompe's disease
Popliteal pterygium syndrome
Porencephaly
Porphyria
Porphyria cutanea tarda
Portal hypertension
Portal vein thrombosis
Post Polio syndrome
Post-traumatic stress...
Postural hypotension
Potophobia
Poxviridae disease
Prader-Willi syndrome
Precocious puberty
Preeclampsia
Premature aging
Premenstrual dysphoric...
Presbycusis
Primary biliary cirrhosis
Primary ciliary dyskinesia
Primary hyperparathyroidism
Primary lateral sclerosis
Primary progressive aphasia
Primary pulmonary...
Primary sclerosing...
Prinzmetal's variant angina
Proconvertin deficiency,...
Proctitis
Progeria
Progressive external...
Progressive multifocal...
Progressive supranuclear...
Prostatitis
Protein S deficiency
Protein-energy malnutrition
Proteus syndrome
Prune belly syndrome
Pseudocholinesterase...
Pseudogout
Pseudohermaphroditism
Pseudohypoparathyroidism
Pseudomyxoma peritonei
Pseudotumor cerebri
Pseudovaginal...
Pseudoxanthoma elasticum
Psittacosis
Psoriasis
Psychogenic polydipsia
Psychophysiologic Disorders
Pterygium
Ptosis
Pubic lice
Puerperal fever
Pulmonary alveolar...
Pulmonary hypertension
Pulmonary sequestration
Pulmonary valve stenosis
Pulmonic stenosis
Pure red cell aplasia
Purpura
Purpura, Schoenlein-Henoch
Purpura, thrombotic...
Pyelonephritis
Pyoderma gangrenosum
Pyomyositis
Pyrexiophobia
Pyrophobia
Pyropoikilocytosis
Pyrosis
Pyruvate kinase deficiency
Uveitis
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Read more at Wikipedia.org


[List your site here Free!]


Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis
From CHEST, 10/1/05 by Fang Chi Lin

PURPOSE: To evaluate the clinical relevance of anti-GM-CSF anti-bodies in idiopathic pulmonary proteinosis.

METHODS: Twelve idiopathic pulmonary alveolar proteinosis patients were examined on 19 occasions. To serve as controls, 2 patients with secondary pulmonary alveolar proteinosis, 54 patients with other pulmonary disorders, and 11 subjects without lung lesions were studied.

RESULTS: Anti-GM-CSF antibodies were detected using immunoblotting analysis and the titers determined semiquantitatively by serial dilution. Clinical parameters used to indicate severity of idiopathic pulmonary alveolar proteinosis were measured. Anti-GM-CSF antibodies were detected in 18 of 19 (95%) blood and 12 of 19 (63%) bronchoalveolar lavage fluid samples in 12 idiopathic pulmonary alveolar proteinosis patients on 19 occasions, but were absent in blood and bronchoalveolar lavage fluid samples obtained from all other studied subjects. Blood levels of anti-GM-CSF antibodies showed no significant correlation with the clinical variables indicative of severity of idiopathic pulmonary alveolar proteinosis. In contrast, the levels of bronchoalveolar lavage fluid anti-GM-CSF antibodies correlated significantly with those of serum lactate dehydrogenase, arterial oxygen tension, alveolar-arterial PO2 difference, ventilatory parameters, and all lung lesion scores measured on chest radiographs and thoracic computed tomography scans.

CONCLUSION: Our results confirmed that the presence of anti-GM-CSF antibodies in blood or bronchoalveolar lavage could serve as a diagnostic marker for idiopathic pulmonary alveolar proteinosis. Additionally, bronchoalveolar lavage fluid levels of anti-GM-CSF antibodies correlated well with the severity of idiopathic pulmonary alveolar proteinosis.

CLINICAL IMPLICATIONS: The titers of anti-GM-CSF antibodies in bronchoalveolar lavage fluid may reflect the severity of idiopathic pulmonary alveolar proteinosis.

DISCLOSURE: Fang Chi Lin, None.

Fang Chi Lin MD * Geen-Dong Chang PhD Yi-Chu Chen MD Shi-Chuan Chang PhD Department of Medicine, Yuan-Shan Veteran Hospital, I-Lan, Taiwan ROC

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Pulmonary alveolar proteinosis
Home Contact Resources Exchange Links ebay